Trillium Therapeutics
C$23.33
3
+C$0.11+0.47% Friday 22:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
10NovExpected
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TRIL.TO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Mississauga, Canada.
Show more...
CEO
Dr. Jan Skvarka
Employees
33
Country
CA
Listings
0 Comments
Share your thoughts
FAQ
What is Trillium Therapeutics stock price today?▼
The current price of TRIL.TO is C$23.33 CAD — it has increased by +0.47% in the past 24 hours. Watch Trillium Therapeutics stock price performance more closely on the chart.
What is Trillium Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Trillium Therapeutics stocks are traded under the ticker TRIL.TO.
How many employees does Trillium Therapeutics have?▼
As of April 02, 2026, the company has 33 employees.
In which sector is Trillium Therapeutics located?▼
Trillium Therapeutics operates in the Healthcare sector.
When did Trillium Therapeutics complete a stock split?▼
Trillium Therapeutics has not had any recent stock splits.
Where is Trillium Therapeutics headquartered?▼
Trillium Therapeutics is headquartered in Mississauga, CA.